While cocrystal engineering is an emerging formulation strategy to overcome drug delivery challenges, its therapeutic potential in non-oral applicatio...Read more

While inhalable nanoparticle-based dry powders have demonstrated promising potential as next-generation respiratory medicines, erratic particle redisp...Read more

Dexamethasone (DEX), a widely prescribed anti-inflammatory drug, displays limited crystal forms. Cocrystallization constitutes an untapped strategy fo...Read more

Formulating pharmaceutical cocrystals as inhalable dosage forms represents a unique niche in effective management of respiratory infections. Favipirav...Read more